LexDanaLexDanabeta
Inventor

Huifeng Niu

Inventor
Scotch Plains, NJ, US

Overview

3→
Patents
2016–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides29%
PatentTitleYear
9,926,379'Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5'20189,724,354'Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase'20179,409,961'Cell penetrating peptides to target EIF4E'2016

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2016Patents assigned to HOFFMANN LA ROCHE (1)· patent assignee history
2016–2018Based in Scotch Plains, NJ, US· patent location history
2017Patents assigned to MILLENNIUM PHARM INC (1)· patent assignee history
2017Based in Cambridge, MA, US· patent location history
2018Patents assigned to ROCHE GLYCART AG (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE12016
MILLENNIUM PHARM INC12017
ROCHE GLYCART AG12018
Locations
LocationPatentsSpan
Scotch Plains, New Jersey, US22016–2018
Cambridge, Massachusetts, US12017